An Analysis of Applicants Presenting to a Medical Marijuana Specialty Practice in California
- PMID: 23750291
- PMCID: PMC3673028
- DOI: 10.2202/1941-2851.1017
An Analysis of Applicants Presenting to a Medical Marijuana Specialty Practice in California
Abstract
For more than a decade, medical marijuana has been at the forefront of the marijuana policy debate in the United States. Fourteen states allow physicians to recommend marijuana or provide a legal defense for patients and physicians if prosecuted in state courts; however, little is known about those individuals using marijuana for medicinal purposes and the symptoms they use it for. This study provides descriptive information from 1,655 patients seeking a physician's recommendation for medical marijuana, the conditions for which they seek treatment, and the diagnoses made by the physicians. It conducts a systematic analysis of physician records and patient questionnaires obtained from consecutive patients being seen during a three month period at nine medical marijuana evaluation clinics belonging to a select medical group operating throughout the State of California. While this study is not representative of all medical marijuana users in California, it provides novel insights about an important population being affected by this policy.
References
-
- Abrams DI, Jay CA, Shade SB, Vizoso H, Reda H, Press S, et al. Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology. 2007;68(7):515–521. - PubMed
-
- Ben Amar M. Cannabinoids in medicine: A review of their therapeutic potential. Journal of Ethnopharmacology. 2006;105(1–2):1–25. - PubMed
-
- Bestard JA, Toth CC. An open-label comparison of nabilone and gabapentin as adjuvant therapy or monotherapy in the management of neuropathic pain in patients with peripheral neuropathy. Pain Practice. 2010 Nov 18; (Epub ahead of print) - PubMed
-
- Corey-Bloom J, Wolfson TJ, Gamst AC, Jin S, Marcotte T, Bentley H, et al. Short-term effects of medicinal cannabis on spasticity in multiple sclerosis. Presented at the 60th Annual Meeting of the American Academy of Neurology; Chicago, IL. 2008. Apr 12–19,
Grants and funding
LinkOut - more resources
Full Text Sources